The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway-Reference-Cited by-同舟云学术

The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway

Published:2022-07 Issue: Volume:293 Page:115261
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Diao Hongtao,Cheng Jiawen,Huang Xueying,Huang Bingying,Shao Xiaoqi,Zhao Jingjing,Lan Dingming,Zhu Qing,Yan Meiling,Zhang Yue,Rong Xianglu,Guo Jiao^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference36 articles.

1. SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models;Andreadou;Biochim. Biophys. Acta (BBA) - Mol. Basis Dis.,2020

2. Loss of 2 Akt (protein kinase B) isoforms in hematopoietic cells diminished monocyte and macrophage survival and reduces atherosclerosis in ldl receptor-null mice;Babaev;Arterioscler. Thromb. Vasc. Biol.,2019

3. Endothelial-to-Mesenchymal transition;Bischoff;Circ. Res.,2019

4. Comprehensive chemical analysis of Zhenshu Tiaozhi formula and its effect on ameliorating glucolipid metabolic disorders in diabetic rats;Cai;Biomed. Pharmacother.,2021

5. Endothelial-to-mesenchymal transition drives atherosclerosis progression;Chen;J. Clin. Invest.,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxysafflor yellow A, a natural food pigment, ameliorates atherosclerosis in ApoE^−/− mice by inhibiting the SphK1/S1P/S1PR3 pathway;Food Science & Nutrition;2024-09-14

2. Gut Aging: A wane from the normal to repercussion and Gerotherapeutic strategies;Heliyon;2024-09

3. Catalpol inhibits HHcy-induced EndMT in endothelial cells by modulating ROS/NF-κB signaling;BMC Cardiovascular Disorders;2024-08-16

4. Platelets could be key regulators of epithelial/endothelial-to- mesenchymal transition in atherosclerosis and wound healing;Medical Hypotheses;2024-08

5. Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment;Pharmaceuticals;2024-07-10